SNB-19

SNB-19
Synonyms	N/A
Pronounce	N/A
Specialty	N/A
Symptoms	Brain tumor symptoms
Complications	Seizures, neurological deficits
Onset	Varies
Duration	Chronic
Types	N/A
Causes	Genetic mutations
Risks	Radiation exposure, family history
Diagnosis	MRI, CT scan, biopsy
Differential diagnosis	N/A
Prevention	N/A
Treatment	Surgery, radiation therapy, chemotherapy
Medication	N/A
Prognosis	Variable
Frequency	Rare
Deaths	N/A

SNB-19 is a human glioblastoma cell line used extensively in cancer research. Glioblastoma is a type of brain tumor that is highly aggressive and difficult to treat. The SNB-19 cell line is derived from a glioblastoma multiforme tumor and is used to study the molecular biology of glioblastoma, as well as to test potential therapeutic agents.

Characteristics

SNB-19 cells exhibit many of the typical features of glioblastoma cells, including rapid proliferation, invasiveness, and the ability to form tumors in animal models. These cells are anchorage-independent, meaning they can grow without being attached to a surface, a characteristic of malignant cells.

Research Applications

The SNB-19 cell line is used in various research applications, including:

• Drug screening: Testing the efficacy of new anticancer drugs.
• Genetic studies: Understanding the role of specific genes in tumor development and progression.
• Signal transduction: Investigating the signaling pathways involved in cell growth and apoptosis.

Culturing SNB-19 Cells

SNB-19 cells are typically cultured in Dulbecco's Modified Eagle Medium (DMEM) supplemented with fetal bovine serum (FBS) and antibiotics. They require a humidified atmosphere with 5% carbon dioxide at 37°C for optimal growth.

See Also

• Glioblastoma
• Cancer cell line
• Oncology research

External Links

• [Link to relevant research articles]